Cycled Phototherapy: A Safer Effective Treatment for Small Premature Infants?

Trial ID or NCT#

NCT01944696

Status

recruiting iconRECRUITING

Purpose

Cycled (intermittent) phototherapy will be compared to continuous (uninterrupted) phototherapy in the treatment of hyperbilirubinemia (newborn jaundice) in extremely low birth weight newborns in a pilot randomized controlled trial. Hypothesis: Cycled phototherapy (PT) will provide the same benefits as continuous phototherapy in extremely low birth weight (ELBW) infants without the risks that have been associated with continuous phototherapy.

Official Title

Cycled Phototherapy: A Safer Effective Treatment for Small Premature Infants?

Eligibility Criteria

Ages Eligible for Study: Younger than 24 Hours
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. - birth weight 401-1000 grams - age less than or equal to 24 hours
Exclusion Criteria:
  1. - hemolytic disease - major anomaly - overt nonbacterial infection

Investigator(s)

David K. Stevenson, M.D.

Contact us to find out if this trial is right for you.

Contact

David K Stevenson, MD
497-0735